Ledger.Open graph →

SEC Form D · filed November 17, 2023

Panbela Therapeutics, Inc

Offering

—

Sold

$3.3M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Waconia, MN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jeffrey E. Jacob · Waconia, MNDirector Jeffrey S. Mathiesen · Waconia, MNDirector Robert S. Schemel · Waconia, MNDirector Arthur J. Fratamico · Waconia, MNDirector Michael T. Cullen · Waconia, MNDirector Jennifer K. Simpson · Waconia, MNExec · Director Daniel S. Donovan · Waconia, MNDirector Susan K. Horvath · Waconia, MNExec Michael T. Cullen · Waconia, MNDirector Jennifer K. Simpson · Waconia, MNExec · Director Robert S. Schemel · Waconia, MNDirector Susan K. Horvath · Waconia, MNExec Jeffrey S. Mathiesen · Waconia, MNDirector Daniel S. Donovan · Waconia, MNDirector Arthur J. Fratamico · Waconia, MNDirector Jeffrey E. Jacob · Waconia, MNDirector Lawrence W. Greer · Birmingham, ALDirector Dirk Van Peteghem · CHICAGO, ILDirector Dennis Mehiel · CHICAGO, ILDirector Joel Bergstein · CHICAGO, ILDirector Todd Lewis · Austin, TXExec Eric Goldreyer · Austin, TXDirector Jennifer Nicolle · St Peter Port, Y7Director David F. Newman · Charlotte, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗